meloxoral
dechra regulatory b.v. - meloxicam - musculo-skeletal system, anti-inflammatory and anti-rheumatic products, non-steroids - dogs; cats - catsalleviation of inflammation and pain in chronic musculoskeletal disorders.dogsalleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.
meloxoral 1.5 mg/ml oral suspension for dogs
le vet beheer b.v. - meloxicam - meloxicam 1.5 g/litre - anti-inflammatory
meloxoral 0.5 mg/ml oral suspension for cats
le vet beheer b.v. - meloxicam - meloxicam 0.5 g/litre - anti-inflammatory
meloxoral 0.5 mg/ml oral suspension for cats
le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - cats
meloxoral 1.5 mg/ml oral suspension for dogs
le vet b.v. - meloxicam - oral suspension - anti inflammatory nsaid - dogs
meloxoral 0.5 mg/ml oral suspension for cats
dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - cats
meloxoral 1.5 mg/ml oral suspension for dogs
dechra regulatory bv - meloxicam - oral suspension - anti inflammatory nsaid - dogs
eloxioral- meloxicam suspension
henry schein animal health - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 1.5 mg in 1 ml - eloxioral oral suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs. dogs with known hypersensitivity to meloxicam should not receive eloxioral oral suspension. do not use eloxioral oral suspension in cats. acute renal failure and death have been associated with the use of meloxicam in cats.
meloxicam tablet
international laboratories, llc - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam is contraindicated in the following patients: • known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] • history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7,5.8) ] • in the setting of coronary artery bypass graft (cabg) surger
meloxicam tablet
american health packaging - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 15 mg - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1)]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2)]. meloxicam is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9)] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic r